Perinatal transmission of HIV and diagnosis of HIV infection in infants: A review

Irish Journal of Medical Science

Volumn 167, Issue 1, 1998, Pages 28-32

  Nourse, C B ^a,b   Butler, K M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERIMMUNE GLOBULIN; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; DELIVERY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT FEEDING; IRELAND; MATERNAL DISEASE; MEMBRANE RUPTURE; NEWBORN; OBSTETRIC CARE; ORAL DRUG ADMINISTRATION; PREGNANCY; RISK FACTOR; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS LOAD;

EID: 0031890045     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02937550     Document Type: Article

References (66)

1. World Health Organisation, AIDS-global data. Wkly. Epidemiol. Rec. 1995; 70: 353-355.
2. Chin, J., Mann, J. M. Global surveillance and forecasting of AIDS. Bull. World Health Organ. 1997; 336: 1-7.
3. Buehler, J. W:, Berkelman, R. L., Curran, J. W. Reporting of AIDS: tracking HIV morbidity and mortality. JAMA 1989; 262: 2896-2897.
4. Chrystie, I. L., Palmer, S. J., Kenny, A., Banatvala, J. E. HIV Seroprevalence among women attending antenatal clinics in London. Lancet 1992; 339: 364.
5. McLaws, M., Brown, A., Cunningham, P., Imrie, A., Wilcken, B., Cooper, D. Prevalence of maternal HIV infection based on anonymous testing of neonates, Sydney 1989. Med. J. Aust. 1990; 153.
6. Ades, A., Parker, S., Berry, T., Holland, F. Prevalence of maternal HIV-1 infection in Thames Regions: results from anonymous unlinked neonatal testing. Lancet 1991; 337: 1562-1565.
7. Schechter, M. T., Ballem, P. J., Buskard, N. A. An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon teritory. Can. Med. Assos. J. 1990; 143: 1187-1192.
8. Ippolito, G., Stegagno, M., Girardi, E., Costa, F., Rava, L., Aebischer, M. L. Temporal and geographical trends of anti-HIV-1 antibodies screening among newborns in Italy, 1990-1993. Italian Collaborative Study Group for HIV Prevalence in Newborns. Journal of Acquired Immune Deficiency Syndromes 1996; 12:63-68.
9. Leroy, V, Van de Perre, P., Lepage, P. et al. Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS 1994; 8: 983-986.
10. Batter, V., Matela, B., Nsuami, M., et al. High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaire: estimating incidence from serial seroprevalence data. AIDS 1994; 8: 811-817.
11. Anonymous. Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country. Rwandan HIV Seroprevalence Study Group. Lancet 1989; 1: 941-943.
12. Allen, S., Lindan, C., Serufilira, A. et al. Human immunodeficiency virus infection in urban Rwanda Demographic and behavioral correlates in a representative sample of childbearing women. JAMA 1991; 266: 1657-1663.
13. Ryder, R., Nsa, W., Hassig, S., Behets, F. Perinatal transmission of the Human Immunodeficiency virus Type 1 to infants of seropositive women in Zaire. N. Engl. J. Med. 1989; 320: 1637-1642.
14. Braddick, M. R., Kreiss, J. K., Embree, J. E. Impact of maternal HIV infection on obstetrical and neonatal outcome. AIDS 1990; 1001-1005.
15. Temmerman, M., Chomba, E. N., Ndinya-Achola, J., Plummer, F. A., Coppens, M., Piot, P. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet. Gynecol. 1994; 83: 495-501.
16. Minkoff, H., Henderson, C., Mendez, H. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am. J. Obstet. Gynecol. 1990; 163: 1598-1604.
17. Johnstone, F., MacCullum, L. Does infection with HIV affect the outcome of pregnancy? BMJ 1988; 296.
18. Langston, C., Lewis, D. E., Hammill, H. A. et al. Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection. J. Infect. Dis. 1995; 172: 1451-1460.
19. European Collaborative Study. Mother to child transmission of HIV infection. Lancet 1988; 2: 1039-1043.
20. European Collaborative Study. Risk factors for mother to child transmission of HIV-1. Lancet 1992; 339: 1007-1012.
21. Halsey, N. A., Boulos, R., Holt, E., et al. Transmission of HIV-1 infections from mothers to infants in Haiti. Impact on childhood mortality and malnutrition. The CDS/JHU AIDS Project Team. JAMA 1990; 264: 2088-2092.
22. Hira, S. K., Kamanga, J., Bhat, G. J. et al. Perinatal transmission of HIV-1 in Zambia. BMJ 1989; 299: 1250-1252.
23. Blanche, S., Rouzioux, C., Moscato, M. L. et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N. Engl. J. Med. 1989; 320: 1643-1648.
24. Nesheim, S. R., Lindsay, M., Sawyer, M. K., et al. A prospective population-based study of HIV perinatal transmission. AIDS 1994; 8: 1293-1298.
25. Peckham, C., Gibb, D. Mother-to-child transmission of the human immunodeficiency virus. N. Engl. J. Med. 1995; 333: 298-302.
26. The Working Group on mother-to-child transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J. Acquir. Immune Defic. Syndr. 1995; 8: 1495-1497.
27. Ehrnst, A., Lindgren, S., Dictor, M. et al. HIV in pregnant women and their offspring: evidence for late transmission . Lancet 1991; 338: 203-207.
28. Bryson, Y. J., Luzuriaga, K., Sullivan, J. L., Wara, D. W. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N. Engl. J. Med. 1992; 327: 1246-1247.
29. Rouzioux, C., Costagliola, D., Burgard, M. et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. American Journal of Epidemiology 1995; 142: 1330-1337.
30. Kalish, L.A., Pitt, J., Lew, J. et al. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. J. Infect. Dis. 1997; 175: 712-715.
31. Shearer, W. T., Quinn, T. C., Larussa, P. et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N. Engl. J. Med. 1997; 336: 1337-1342.
32. The European Collaborative Study, Vertical transmission of HIV-1 : maternal immune status and obstetric factors. AIDS 1996; 10: 1675-1681.
33. Mandelbrot, L., Mayaux, M., Bongain, A. et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1 : The French perinatal cohorts. N. Engl. J. Med. 1994; 331: 1173-1180.
34. Thomas, P. A., Weedon, J., Krasinski, K. et al. Maternal predictors of perinatal human immunodeficiency virus transmission. The New York City Perinatal HIV Transmission Collaborative Study Group. Pediatr. Infect. Dis. J. 1994; 13: 489-495.
35. Tibaldi, C., Tovo, P. A., Ziarati, N. et al. Asymptomatic women at high risk of vertical HIV-1 transmission to their fetuses . Br. J. Obs. Gynae. 1993; 100: 334-337.
36. Pitt, J., Brambilla, D., Reichelderfer, P. et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection - Findings from the women and infants transmission study. J. Infect. Dis. 1997; 175: 567-575.
37. Boyer, P. J., Dillon, M., Navaie, M., Deveikis, A., Keller, M., O'Rourke, S. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery . JAMA 1994; 271: 1925-1930.
38. Roques, P., Marce, D., Courpotin, C. et al. Correlation between HIV provirus burden and in utero transmission. AIDS 1993; 7 Suppl 2: S39-S43.
39. St Louis, M. E., Kamenga, M., Brown, C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993; 269: 2853-2859.
40. Dickover, R. E., Garratty, E. M., Herman, S. A. et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996; 275: 599-605.
41. Borkowsky, W., Krasinski, K., Cao, Y. et al. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J. Paeds. 1994; 125: 345-351.
42. Fang, G., Burger, H., Grimson, R. et al. Maternal plasma human immunodefiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission. Proc. Natl. Acad. Sci. 1995; 92: 12100-12104.
43. Zollner, B., Heinz-Hubert, F., Helling-Geise, G., Schroter, M., Laufs, R. HIV quantification: useful for prediction of vertical transmission? Lancet 1996; 347:899.
44. Coll, O., Hernandez, M., Boucher, C. A. B. et al. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997; 14: 26-30.
45. Mayaux, M. J., Dussaix, E., Isopet, J. et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1 : The French perinatal cohort studies. J. Infect. Dis. 1997; 175: 172-175.
46. Kliks, S. C., Wara, D. W., Landers, D. V, Levy, J. A., Features of HIV-1 that could influence maternal-child transmission. JAMA 1994; 272: 467-474.
47. Goedert, J. J., Duliege, A. M., Amos, C. I., Felton, S., Biggar, R. J. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet 1991 ; 338: 1471-1475.
48. Villari, P., Spino, C., Chalmers, T. C., Lau, J., Sacks, H. S.. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. Online J. Curr. Clin. Trials 1993; Doc. No 74.
49. Anonymous, Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study. Lancet 1994;343:1464-1467.
50. Thiry, L., Sprecher-Goldberger, S., Jonckheer, T. et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers . Lancet 1985; 2: 891-892.
51. Van de Perre, P., Simonon, A., Hitimana, D. G. et al. Infective and anti-infective properties of breastmilk from HIV-1-infected women . Lancet 1993; 341: 914-918.
52. Buranasin, P., Kunakorn, M., Petchclai, B., Raksakait, K., Wichukchinda, N., Thongcharoen, P. Detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in breast milk and colostrum of seropositive mothers. J. Med. Assoc. Thai. 1993; 76: 41-45.
53. Villari, P., Cooper, D. A., Johnson, R. O., Gold, J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985; 1: 896-898.
54. Anonymous. Global programme on AIDS. Consensus statement from the WHO/UNICEF consultation on HIV transmission and breast-feeding. Wkly. Epidemiol. Rec. 1992; 67: 177-179.
55. Connor, E. M., Sperling, R. S.,Gelber, R. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med. 1994; 331: 1173-1180.
56. Frenkel, L. M., Cowles, M. K., Shapiro, D. E. et al. Analysis of the maternal components of the AIDS Clinical Trial Group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J. Infect. Dis. 1997; 175: 971-974.
57. Lambert, J. S., Mofenson, L. M., Fletcher, C. V. et al. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J. Infect. Dis. 1997; 175: 283-291.
58. Fransen, K., Pollet, D. E., Peeters, M. et al. Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2. Eur. J. Clin. Microbiol. Infect. Dis. 1991; 10: 939-946.
59. Church, J. A. The diagnostic challenge of the child born "at risk" for HIV infection. Pediatr. Clin. North Am. 1994; 41: 715-726.
60. Palumbo, P. Laboratory findings in HIV infection in infancy. Clin. Perinatol. 1994; 21: 109-124.
61. Nesheim, S., Lee, F., Kalish, M. L. et al. Diagnosis of perinatal human immunodeficiency virus infection by polymerase chain reaction and P24 detection after immune complex dissociation in an urban community hospital. J. Infect. Dis. 1997; 175: 1333-1336.
62. Kline, M. W., Lewis, D. E., Hollinger, F. B. et al. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 1994; 13: 90-94.
63. Rogers, M. F., Ou, C. Y., Rayfield, M. et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N. Engl. J. Med. 1989; 320: 1649-1654.
64. Comeau, A. M., Harris, J. A., McIntosh, K., Weiblen, B. J., Hoff, R., Grady, G. F. Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. Journal of Acquired Immune Deficiency Syndromes 1992; 5: 271-278.
65. Burgard, M., Mayaux, M. J., Blanche, S. et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. N. Engl. J. Med. 1992; 327: 1192-1197.
66. Steketee, R. W., Abrams, E. J., Thea, D. M., et al. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. J. Infect. Dis. 1997; 175: 707-711.